Classification of atypical EGFR mutations in non-small-cell lung cancer

被引：0
|
作者：
Rosell, R. [1 ,2 ,3 ]
Cardona, A. F. [4 ]
Arrieta, O. [5 ]
Gonzalez-Cao, M. [1 ,2 ]
机构：
[1] Inst Germans Trias I Pujol IGTP, Canc Biol & Precis Med Lab, Badalona, Spain
[2] Quiron Dexeus Univ Hosp, Oncol Inst Dr Rosell IOR, Barcelona, Spain
[3] Catalan Inst Oncol ICO, Barcelona, Spain
[4] Clin & Translat Oncol Grp, Clin Country, Bogota, Colombia
[5] Natl Inst Cancerology INCAN, Thorac Oncol Unit, Mexico City, DF, Mexico
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷 / 06期
关键词：
D O I：
10.1016/j.annonc.2022.03.010
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：571 / 573
页数：3
相关论文
共 50 条
  • [31] Treatment of Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in Clinical Practice
    Yamada, Yutaka
    Tamura, Tomohiro
    Yamamoto, Yusuke
    Ichimura, Hideo
    Hayashihara, Kenji
    Saito, Takefumi
    Yamada, Hideyasu
    Endo, Takeo
    Nakamura, Ryota
    Inage, Yoshihisa
    Satoh, Hiroaki
    Iguchi, Kesato
    Saito, Kazuto
    Inagaki, Masaharu
    Kikuchi, Norihiro
    Kurishima, Koichi
    Ishikawa, Hiroichi
    Sakai, Mitsuaki
    Kamiyama, Koichi
    Shiozawa, Toshihiro
    Hizawa, Nobuyuki
    Sekine, Ikuo
    Sato, Yukio
    Funayama, Yasunori
    Miyazaki, Kunihiko
    Kodama, Takahide
    Hayashi, Shigen
    Nomura, Akihiro
    Nakamura, Hiroyuki
    Furukawa, Kinya
    Yamashita, Takaaki
    Okubo, Hatsumi
    Suzuki, Hisashi
    Kiyoshima, Moriyuki
    Kaburagi, Takayuki
    [J]. ANTICANCER RESEARCH, 2020, 40 (10) : 5757 - 5764
  • [32] Nivolumab in non-small-cell lung cancer with EGFR mutation
    Yoshida, H.
    Kim, Y. H.
    Ozasa, H.
    Nagai, H.
    Sakamori, Y.
    Tsuji, T.
    Nomizo, T.
    Yasuda, Y.
    Funazo, T.
    Hirai, T.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (03) : 777 - 778
  • [33] EGFR mutation analysis in non-small-cell lung cancer
    Tapia, C.
    Savic, S.
    Bihl, M.
    Rufle, A.
    Zlobec, I.
    Terracciano, L.
    Bubendorf, L.
    [J]. PATHOLOGE, 2009, 30 (05): : 384 - 392
  • [34] EGFR MUTATIONS IN NON-SMALL-CELL LUNG CANCERS: A SINGLE INSTITUTE EXPERIENCE
    Maka, V. V.
    Subramaniam, M.
    Kilara, N.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 : E59 - E60
  • [35] Intrinsic resistance to EGFR tyrosine kinase inhibitors in advanced non-small-cell lung cancer with activating EGFR mutations
    Wang, Jun
    Wang, Baocheng
    Chu, Huili
    Yao, Yunfeng
    [J]. ONCOTARGETS AND THERAPY, 2016, 9 : 3711 - 3726
  • [36] KRAS mutations in non-small-cell lung cancer and colorectal cancer: Implications for EGFR-targeted therapies
    Maus, M. K. H.
    Grimminger, P. P.
    Mack, P. C.
    Astrow, S. H.
    Stephens, C.
    Zeger, G.
    Hsiang, J.
    Brabender, J.
    Friedrich, M.
    Alakus, H.
    Hoelscher, A. H.
    Lara, P.
    Danenberg, K. D.
    Lenz, H. J.
    Gandara, D. R.
    [J]. LUNG CANCER, 2014, 83 (02) : 163 - 167
  • [37] New driver mutations in non-small-cell lung cancer
    Pao, William
    Girard, Nicolas
    [J]. LANCET ONCOLOGY, 2011, 12 (02): : 175 - 180
  • [38] Infra-tumor heterogeneity in non-small-cell lung cancer (NSCLC) carrying EGFR mutations
    Rachiglio, Anna Maria
    lambiase, Matilde
    Fenizia, Francesca
    Morabito, Alessandro
    Rocco, Gaetano
    Galetta, Domenico
    Ludovini, Vienna
    Vincenzi, Bruno
    Barletta, Emiddio
    Botti, Gerardo
    Normanno, Nicola
    [J]. CANCER RESEARCH, 2016, 76
  • [39] Isolation of circulating tumor cells and detection of EGFR mutations in patients with non-small-cell lung cancer
    Zhang, Qi
    Nong, Jingying
    Wang, Jinghui
    Yan, Zhuohong
    Yi, Ling
    Gao, Xin
    Liu, Zhidong
    Zhang, Hongtao
    Zhang, Shucai
    [J]. ONCOLOGY LETTERS, 2019, 17 (04) : 3799 - 3807
  • [40] Does sarcopenia affect outcome in patients with non-small-cell lung cancer harboring EGFR mutations?
    Rossi, Sabrina
    Di Noia, Vincenzo
    Tonetti, Laura
    Strippoli, Antonia
    Basso, Michele
    Schinzari, Giovanni
    Cassano, Alessandra
    Leone, Antonio
    Barone, Carlo
    D'Argento, Ettore
    [J]. FUTURE ONCOLOGY, 2018, 14 (10) : 919 - 926
12345